In general, people around the world are eating better and living longer, but they are also moving less. This is contributing to the rise of diabetes, a condition that affects 422 million people and is fast becoming a major problem, especially in poor countries.
Two factors are critical for the successful treatment of diabetes patients. First is a correct diagnosis of the type of the disease, and second is the administration of the appropriate drugs.
A misdiagnosis and, consequently, the wrong treatment can cause many problems.
“If you label someone who actually has type 2 diabetes as type 1, they'll be left on insulin for the rest of their life when they don't need it," said Dr. Richard Oram of the U.K. National Institute for Health Research. "Even worse, if someone with type 1 diabetes is mislabeled as having type 2 diabetes, then they may not be treated with the insulin they need, and they may suffer life-threatening complications.”
A new, less expensive test, developed at the University of Exeter Medical School, measures 30 genetic variants in the patient’s DNA and calculates the risk for type 1 or type 2. Individual diagnoses can be completed with a commonly used test for antibodies.
Scientists are now trying to develop an even simpler DNA-based test that could be done with a smartphone app.
No more injections?
In the meantime, researchers in South Korea are developing a nanotechnology-based adhesive strip that takes away pain and stress of daily injections for diabetes patients.
“The device is a patch type that enables [diabetics] to monitor blood sugar levels via sweat without taking blood samples and injections, as well as to control glucose levels by injecting medication,” said Kim Dae-hyeong, a professor in the School of Chemical and Biological Engineering at Seoul National University.
The patch is studded with microneedles that painlessly enter subcutaneous tissue. When the connected chip senses that the level of glucose has risen above normal, a small heating element dissolves medication and releases it into the bloodstream.
Tests done on lab mice were promising, so scientists hope they will soon start testing the patch on humans. In this phase, experiments are still expensive, but scientists say the price will drop once it the patch is ready for mass production.
Vocabulary
misdiagnosis: 误诊,漏诊
A new frontier for China
Rivals to rest on Fourth of July break
Leaders say violence in Syria must end
Public bike rental wheels into Beijing
Food safety becomes national priority
Alien species a growing menace: experts
Replica of London Games torch to be sold in China
Tourists may get 3-day visit window
Software piracy declined in 2011
Asians top immigrant group to US
Report tracks China's growth
Hand, foot, mouth disease kills 240
Fake stewed pig ears pose health risks
UK binge drinking 'at crisis levels'
Victim of beating that sparked LA riots dies
Lady Gaga cancels Indonesia show
Putin's Israeli visit to focus on Iran
Japan 'must end outdated policy'
New rule to rein in spending
US apologizes for discriminatory laws
Draft law targets work permits
Eight miners rescued from coal mine accident
Crackdown on antibiotic abuse
Adopted children discover China
Wanted: A new home for 400 cats and dogs
Water source in HK, Macao safe
Muslim Brotherhood's success in Egypt polls masks setback
Egypt's army says it will hand over power
Foreigners receiving more legal support
UN report sounds alarm to clean up oceans
| 不限 |
| 英语教案 |
| 英语课件 |
| 英语试题 |
| 不限 |
| 不限 |
| 上册 |
| 下册 |
| 不限 |